Intermountain Ventures is collaborating with a health tech startup to earlier identify cases of multiple sclerosis.
The venture capital and innovation arm of Salt Lake City-based Intermountain Health has partnered with Canary Speech to study whether AI-powered vocal analysis can accurately detect the condition in patients.
“The ability to use voice to identify MS would offer a quick, noninvasive screening tool, enabling us to deliver faster care to patients,” said Timothy West, MD, a neurologist at Intermountain Health’s Salt Lake Clinic, in a Feb. 10 news release.
Dr. West will lead the research, collecting voice samples from local patients and analyzing them with Canary Speech’s AI-driven algorithms.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.